Literature DB >> 7835578

Scanning electron-microscopic lesions in Crohn's disease: relevance for the interpretation of postoperative recurrence.

E Nagel1, M Bartels, R Pichlmayr.   

Abstract

BACKGROUND/AIMS: Endoscopic postoperative recurrence often occurs a few months after surgical therapy for Crohn's disease, even if the resection margins were macroscopically free of disease. Why the disease primarily recurs at the anastomotic site is not known. This study investigated resection margins in Crohn's disease in an attempt to clarify whether early lesions are relevant to the interpretation of postoperative recurrence.
METHODS: Specimens of surgically resected bowel from 29 patients with Crohn's disease and tissue from 11 controls were studied with a scanning electron microscope.
RESULTS: In Crohn's disease, a triad of early lesions occurring in both histopathologically unaffected and affected mucosa was revealed; the triad consisted of mucosal architectural alterations, epithelial bridge formation, and goblet-cell hyperplasia or hypertrophy or both. Seventy-three percent of patients showed early alterations within histopathologically unaffected margins in the small bowel, and 71% had such alterations in the large bowel.
CONCLUSIONS: The findings provide further evidence for the concept of diffuse involvement of the whole gastrointestinal tract by the disease process. The endoscopic recurrence rate in the first year after the operative procedure is almost identical to the number of early lesions present during surgery. The term "postoperatively recurrent disease" should be used only if relevant clinical parameters change.

Entities:  

Mesh:

Year:  1995        PMID: 7835578     DOI: 10.1016/0016-5085(95)90063-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

1.  Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial.

Authors:  V W Fazio; F Marchetti; M Church; J R Goldblum; C Lavery; T L Hull; J W Milsom; S A Strong; J R Oakley; M Secic
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

2.  Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.

Authors:  W Reinisch; K H Heider; G Oberhuber; C Dejaco; M Müllner; G R Adolf; C Gasché
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

Review 3.  Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

Review 4.  Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.

Authors:  W M Bauer; A Brzezinski; B A Lashner
Journal:  Curr Gastroenterol Rep       Date:  1999-10

5.  Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.

Authors:  J M Reimund; C Wittersheim; S Dumont; C D Muller; J S Kenney; R Baumann; P Poindron; B Duclos
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

6.  Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease.

Authors:  J D Söderholm; G Olaison; K H Peterson; L E Franzén; T Lindmark; M Wirén; C Tagesson; R Sjödahl
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

7.  Could Mycobacterium avium subspecies paratuberculosis cause Crohn's disease, ulcerative colitis…and colorectal cancer?

Authors:  Ellen S Pierce
Journal:  Infect Agent Cancer       Date:  2018-01-04       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.